Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China flag China · Delayed Price · Currency is CNY
61.66
-2.77 (-4.30%)
Nov 17, 2026, 3:00 PM CST

Beijing Hotgen Biotech Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
472.32404.88509.78547.843,5575,369
Revenue Growth
9.55%-20.58%-6.95%-84.60%-33.76%945.54%
Gross Profit
294.44225.28253.84336.111,7903,116
Operating Income
-354.26-274.23-211.74-45.551,0952,574
Net Income
-299.1-216.05-205.7728.92944.742,186
Earnings Per Share
-3.15-2.36-2.360.3310.2823.75
EPS Growth
----96.81%-56.72%1852.80%

Revenue by Geography

Fiscal Year
FY 2025
Period EndingDec '25
Overseas
21.96
China
373.5
Total
395.46

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0671,3671,085606.131,4632,089
Total Debt
0.0550.4942.915.2642.1335.98
Net Cash (Debt)
1,0671,3171,042590.871,4212,053
Net Cash Growth
2.34%26.39%76.31%-58.42%-30.77%436.43%
Net Cash Per Share
11.2314.3811.956.6915.4622.30

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-176.13-83.36-90.16-48.53978.752,644
Capital Expenditures
-119.67-43.57-52.82-413.37-565.21-398.86
Free Cash Flow
-295.8-126.93-142.98-461.9413.542,246
Free Cash Flow Growth
-----81.58%-

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.34%55.64%49.79%61.35%50.34%58.03%
Operating Margin
-75.00%-67.73%-41.53%-8.31%30.79%47.93%
Pretax Margin
-85.71%-66.01%-44.22%2.74%30.23%48.09%
Profit Margin
-63.32%-53.36%-40.36%5.28%26.56%40.71%
FCF Margin
-62.63%-31.35%-28.05%-84.31%11.63%41.82%

Dividends

Fiscal Year
FY 2023FY 2022FY 2021
Period EndingDec '23 Dec '22 Dec '21
Dividend Per Share
0.200-3.378
Dividend Per Share Growth
--233.34%
Dividend Yield
0.49%-4.30%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---126.905.933.31
Forward PE
-228.67135.1733.4033.4033.40
P/FCF Ratio
----13.563.22
PS Ratio
11.5135.5410.876.701.581.35